NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability.
Meredith L.L. Leong, Weiqun Liu, Nicole C. Fay, Diane M Da Silva, Li Ou, Chris S. Rae, Adrienne Sallets, Ruben Prins, Daniel O. Frimannsson, Colin J. McKinlay, Ray Lieh Yoon Low, Daniel J. Fernandez, Gunasekaran Kannan, Pragyesh Dhungel, Sangeeta Nath, , Ole Audun Werner Haabeth
This paper introduces NTX250, an mRNA-based immunotherapy platform for HPV-associated cancers that induces tumor regression and durable immune memory in preclinical models.
bioRxiv · Sep 24, 2025 · PreprintImmunology